Abstract
BackgroundCytoTIL15® therapy is an IL2-independent, engineered TIL product which allows pharmacological control of membrane-bound IL15 (mbIL15). We have previously shown that cytoTIL15® TILs demonstrate enhanced persistence and anti-tumor efficacy in...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have